Literature DB >> 12953696

Adalimumab.

Bornadata Bain1, Melanie Brazil.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12953696     DOI: 10.1038/nrd1182

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  8 in total

1.  Femtomolar Fab binding affinities to a protein target by alternative CDR residue co-optimization strategies without phage or cell surface display.

Authors:  Christian Votsmeier; Hanna Plittersdorf; Oliver Hesse; Andreas Scheidig; Michael Strerath; Uwe Gritzan; Klaus Pellengahr; Peter Scholz; Andrea Eicker; David Myszka; Wayne M Coco; Ulrich Haupts
Journal:  MAbs       Date:  2012-04-26       Impact factor: 5.857

Review 2.  Visceral adiposity, inflammation, and hippocampal function in obesity.

Authors:  Alexis M Stranahan
Journal:  Neuropharmacology       Date:  2021-12-10       Impact factor: 5.273

Review 3.  Challenges in Antibody Development against Tn and Sialyl-Tn Antigens.

Authors:  Liliana R Loureiro; Mylène A Carrascal; Ana Barbas; José S Ramalho; Carlos Novo; Philippe Delannoy; Paula A Videira
Journal:  Biomolecules       Date:  2015-08-11

4.  Efficacy and safety of adalimumab by intra-articular injection for moderate to severe knee osteoarthritis: An open-label randomized controlled trial.

Authors:  Jianping Wang
Journal:  J Int Med Res       Date:  2017-08-25       Impact factor: 1.671

Review 5.  Genetic, cellular and immune approaches to disease therapy: past and future.

Authors:  Gary J Nabel
Journal:  Nat Med       Date:  2004-02       Impact factor: 53.440

6.  Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumour necrosis factor response in rheumatoid arthritis.

Authors:  C Potter; K L Hyrich; A Tracey; M Lunt; D Plant; D P M Symmons; W Thomson; J Worthington; P Emery; A W Morgan; A G Wilson; J Isaacs; A Barton
Journal:  Ann Rheum Dis       Date:  2008-03-28       Impact factor: 19.103

7.  Targeting Tumor Necrosis Factor-α with Adalimumab: Effects on Endothelial Activation and Monocyte Adhesion.

Authors:  Raghav Oberoi; Jutta Schuett; Harald Schuett; Ann-Kathrin Koch; Maren Luchtefeld; Karsten Grote; Bernhard Schieffer
Journal:  PLoS One       Date:  2016-07-28       Impact factor: 3.240

Review 8.  Emerging Roles of Vascular Cell Adhesion Molecule-1 (VCAM-1) in Immunological Disorders and Cancer.

Authors:  Deok-Hoon Kong; Young Kwan Kim; Mi Ra Kim; Ji Hye Jang; Sukmook Lee
Journal:  Int J Mol Sci       Date:  2018-04-02       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.